Clinical Trial Update: A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls [Phase 3]

View source ↗

Summary

This Phase 3 trial update describes a dose-reduction immunobridging and safety study of two human papillomavirus vaccines in Tanzanian girls; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine A
• HPV vaccine B

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Human Papilloma Virus | Phase 3 | Status: ACTIVE_NOT_RECRUITING